Welcome, Guest. Please login or register.
May 28, 2022, 04:56:58 pm

Login with username, password and session length


  • Total Posts: 335
  • Total Topics: 191
  • Online Today: 19
  • Online Ever: 518
  • (January 21, 2020, 05:24:49 pm)
Users Online
Users: 0
Guests: 10
Total: 10


Welcome to the Cancer Health Forums, a round-the-clock discussion area for people who have any type of cancer, their friends and family and others with questions about living with cancer. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Cancer Health Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Beyond Intravenous Vitamin C  (Read 1173 times)

Offline danialthomas

  • Jr. Member
  • **
  • Posts: 58
  • Doctor Of Osteopathy
    • View Profile
    • Thomas Health Blog
Beyond Intravenous Vitamin C
« on: July 28, 2021, 09:36:47 am »
We know from published research that a high concentration of curcumin (turmeric extract) is effective at killing cancer cells without harming normal cells. In addition, a 5-micromolar concentration of curcumin has been found to reduce the amount of cisplatin (chemotherapy drug) needed to kill various types of cancer cells by a remarkable 300-fold.

When synergistic curcumin and low-dose cisplatin are administered as intravenous cyclodextrin-based nanoparticles, the efficacy of curcumin and cisplatin is improved even further by increasing their solubility, stability, and penetration into tumors. Further synergy is achieved by adding intravenous dichloroacetate, oral celecoxib, and hyperthermia:

• By raising the internal temperature of tumors to 43°C with medical electromagnetic hyperthermia, we sensitize cancer cells to the effects of curcumin and cisplatin and increase tumor blood flow to deliver more curcumin, cisplatin, dichloroacetate, and celecoxib deep into tumors.
• Dichloroacetate sensitizes cancer cells to the effects of hyperthermia and cisplatin.
• Curcumin sensitizes cancer cells to dichloroacetate.
• Celecoxib sensitizes cancer cells to the effects of curcumin, cisplatin, and dichloroacetate.
• Cancer cells and cancer stem cells are directly killed in the presence of sufficient heat.
• Hyperthermia triggers a potent immune response by improving immune recognition of cancer cells through the expression of heat-shock proteins (HSPs) and increasing tumor-infiltrating lymphocytes (TILs). The latter can be further enhanced with the use of oral molecular iodine and/or injectable thymosin alpha 1 (Tα1).

Please note that this information for educational purposes only. It is not intended or implied to be a substitute for professional medical advice, diagnosis, treatment, and monitoring by your personal physician. Therefore, I cannot give dosages or treatment guidelines for the above-mentioned items. That is for your personal physician to determine after studying the references below.

Dr. Daniel Thomas, DO, MS
Mount Dora, Florida

Cheng Y, Weng S, Yu L, Zhu N, Yang M, Yuan Y. The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors. Integr Cancer Ther. 2019;18:1534735419876345.
Costantini C, Bellet MM, Pariano M, et al. A Reappraisal of Thymosin Alpha1 in Cancer Therapy. Front Oncol. 2019;9:873.
Huang H, Yu K, Mohammadi A, Karanthanasis E, Godley A, Yu JS. It’s Getting Hot in Here: Targeting Cancer Stem-like Cells with Hyperthermia. J Stem Cell Transplant Biol. 2017;2(2):113.
Kan PC, Chang YJ, Chien CS, Su CY, Fang HW. Coupling Dichloroacetate Treatment with Curcumin Significantly Enhances Anticancer Potential. Anticancer Res. 2018 Nov;38(11):6253-6261.
Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res. 2005 Sep 15;11(18):6738-44.
Li B, Li X, Xiong H, et al. Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells. Oncotarget. 2017;8(31):51748-51757.
Liu B, Yan S, Qu L, Zhu J. Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. Cancer Cell Int. 2017;17:1.
McCubrey JA, Abrams SL, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Libra M, Murata RM, Rosalen PL, Lombardi P, Montalto G, Cervello M, Gizak A, Rakus D, Steelman LS. Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. Adv Biol Regul. 2018 Jan;67:190-211.
Moreno-Vega A, Vega-Riveroll L, Ayala T, et al. Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study. Nutrients. 2019;11(7):1623.
Muñoz, N.M., Minhaj, A.A., Guo, C., Michael, C., & Cressman, E. (2016). Metabolic modulation with dichloroacetate sensitizes cells to hyperthermia in human hepatocellular carcinoma cell lines. Journal of Vascular and Interventional Radiology, 27.
Qiu, N., Li, X. & Liu, J. Application of cyclodextrins in cancer treatment. J Incl Phenom Macrocycl Chem 89, 229–246 (2017).
Olszewski U, Poulsen TT, Ulsperger E, Poulsen HS, Geissler K, Hamilton G. In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds. Clin Pharmacol. 2010;2:177-83.
Ralph SJ, Nozuhur S, Moreno-Sánchez R, Rodríguez-Enríquez S, Pritchard R. NSAID celecoxib: a potent mitochondrial pro-oxidant cytotoxic agent sensitizing metastatic cancers and cancer stem cells to chemotherapy. J Cancer Metastasis Treat 2018;4:49.
Syng-Ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther. 2004 Sep;3(9):1101-8.
Yagawa Y, Tanigawa K, Kobayashi Y, Yamamoto M. Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery. J Cancer Metastasis Treat 2017;3:218-230.
Zhang Q, Zhu B, Li Y. Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy. Front Immunol. 2017 Feb 2;8:71.
Located in Mount Dora, Florida, Dr. Thomas is one of the most educated, experienced, and innovative physicians in North America. Over the past 30 years, he has helped people throughout the United States and Canada to prevent and overcome disease, improve their health, slow aging, and increase their lifespan. As an active translational researcher, Dr. Thomas has spent over 35,000 hours poring over the latest scientific discoveries and translating max. discoveries into promising theories


© 2022 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.